Welcome to precisionFDA

Welcome to PrecisionFDA

A community platform for NGS assay evaluation and regulatory science exploration.

Expert Spotlight:
Adam resnick phd d3bcenter headshot
My Challenge to the PrecisionFDA Community


Adam Resnick, PhD
Children's Hospital of Philadelphia

1. How might the pediatric cancer and rare disease community best engage the precisionFDA NGS assay development community and sponsor the further development of a sustainable compete-to-share ecosystem for collaborative discovery on behalf children?

2. How can the precisionFDA bioinformatics community be better empowered to partner with the pediatric cancer and rare disease community through a shared economy of accessible data and a shared interest in new models of attribution and/or reproducibility of results?

precisionFDA Challenges
Engage and improve NGS software through community challenges
Latest precisionFDA News
Learn about the latest precisionFDA events and news
Community Participants
Centers for Disease Control and Prevention
Natera
NIST
Human Longevity Inc.
Seracare
PharmGKB
GeneDx
Emory Genetics Lab
DNAnexus
Garvan
US House of Representatives
Crystal Genetics
Roche
23andMe
American Heart Association
Broad Institute
Intel
White House Office of Science and Technology Policy
Macrogen
Personalis
Counsyl
Sequenom
Baylor College of Medicine
NIH
Illumina

Dr. Euan Ashley
Dr. Lester Carter
Dr. Russ Altman
Mark Woon
Dr. Snehit Prabhu
Dr. Mark Wright
Dr. Peter Tonellato
Rachel Goldfeder
Dr. Teri Klein
Hans Nelsen
Dr. Dennis P. Wall

The comparison framework uses open-source software by Real Time Genomics
Learn more about precisionFDA
Feedback Feedback